Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neuroendocrine Tumors 3 Gastro-enteropancreatic neuroendocrine tumor 3 Adenoma, Islet Cell 2 Recurrence 1 Pancreatitis 1 Pancreatic Intraductal Neoplasms 1 Meningioma 1 Fistula 1 Duodenal Neoplasms 1 Carcinoid Tumor 1 Acromegaly 1

Interventions

Magnetic Resonance Spectroscopy 7 lutetium Lu 177 dotatate 6 Specimen Handling 5 Bevacizumab 4 gallium Ga 68 dotatate 3 abemaciclib 3 Radiosurgery 3 Proton Therapy 3 Nivolumab 3 pembrolizumab 2 Surveys and Questionnaires 2 Sunitinib 2 Protons 2 Observation 2 ONC206 2 Ipilimumab 2 Hydroxyurea 2 Ga(III)-DOTATOC 2 Everolimus 2 Elasticity Imaging Techniques 2 CTLA-4 Antigen 2 ribociclib 1 regorafenib 1 olaparib 1 neratinib 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1 capivasertib 1 cabozantinib 1 brigatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Meningioma × Octreotide × 1 year × Clear all

NCT06326190 2025-09-16

LUMEN-1

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Recruiting

Meningioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡